(PRESS RELEASE) BANGKOK – HOYA Vision Care, a leader in optical technology innovation, today announced that is has settled its lawsuit1 with Shanghai Weixing Optical, a developer, manufacturer, and distributor of optical lenses in China following extensive negotiations. Under the settlement, Shanghai Weixing Optical issued a significant payment to obtain a license covering sales of Shanghai Weixing Optical products utilizing proprietary Defocus Incorporated Multiple Segment (D.I.M.S.) Technology. The license will end after an agreed phase-out period after which Shanghai Weixing Optical products utilizing proprietary D.I.M.S. Technology will be withdrawn from the market. Sale or export of any Shanghai Weixing Optical products that utilize proprietary D.I.M.S. Technology after the phase-out period (regardless of their name or branding) is prohibited under the agreement.
Myopia is a condition in which visual images come to a focus in front of the retina of the eye, resulting in the blurry appearance of distant objects. Myopia is also commonly known as ‘near-sightedness’. Myopia has risen dramatically among children in China, reaching 76% – 90% among older school children, and can lead to lasting vision problems.
Advertisement
MiYOSMART spectacle lenses, developed in collaboration with PolyU, are a safe, easy to use, effective and non-invasive method to manage myopia in children. Based on a proprietary approach leveraging D.I.M.S Technology (developed based on peripheral hyperopic defocus theory), MiYOSMART spectacle lenses are based on a well-established and widely recognized theory supported by leading researchers. The efficacy of MiYOSMART spectacle lenses, proven by a wide spectrum of evidence, has resulted in over 5 million MiYOSMART spectacle lenses having been purchased by parents across the world since launch in 2018 and August 2023.
HOYA Vision Care is committed to developing innovative solutions to address the growing problem of myopia progression in children and remains steadfast in its approach to collaborate with leading scientific institutes around the world to contribute to better treatment options that are proven effective by robust clinical trials. In addition, HOYA is dedicated to the protection of both consumers and the integrity of its products.
Advertisement